MyoSync Mobile

Health & Fitness

Only for iPhone

Free · Designed for iPhone. Not verified for macOS.

iPhone

The MyoSync app is an innovative digital health mobile app designed to enhance patient care by monitoring daily activities, tracking medication adherence, and vitals. Also facilitating seamless communication between patients and healthcare providers through teleconsultation. Key Features Teleconsultation Virtual Appointments: Schedule and conduct teleconsultations with healthcare providers from the comfort of your home. Patient Education Access tailored educational resources, including articles, videos, and infographics, based on individual health conditions.

  • This app hasn’t received enough ratings or reviews to display an overview.

Bug fixes and stability improvements. Integrated biometric authentication, which can now be enabled from the Account page.

The developer, Vivos Therapuetics, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Health & Fitness
    • Identifiers
    • Usage Data

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Seller
  • Vivos Therapeutics Inc
Size
  • 52.5 MB
Category
  • Health & Fitness
Compatibility
Requires iOS 15.1 or later.
  • iPhone
    Requires iOS 15.1 or later.
  • iPod touch
    Requires iOS 15.1 or later.
  • Mac
    Requires macOS 12.0 or later and a Mac with Apple M1 chip or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
  • English
Age Rating
16+
  • 16+
  • Frequent
    Medical Treatment information

    Contains
    Health or Wellness Topics
Copyright
  • © 2025 Vivos Therapeutics, Inc.